Selected publications
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics. 2020 Academic Article GET IT
-
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Nature Genetics.
2017
Academic Article
GET IT
Times cited: 69 -
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nature Genetics.
2017
Academic Article
GET IT
Times cited: 66 -
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Breast Cancer Research and Treatment.
2017
Academic Article
GET IT
Times cited: 9 -
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 13 -
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Nature Communications.
2016
Academic Article
GET IT
Times cited: 24 -
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 13 -
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology.
2016
Review
GET IT
Times cited: 8 -
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
Nature Communications.
2016
Academic Article
GET IT
Times cited: 38 -
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Nature Genetics.
2016
Review
GET IT
Times cited: 53 -
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 33 -
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Journal of the National Cancer Institute.
2016
Academic Article
GET IT
Times cited: 43 -
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Breast Cancer Research.
2015
Academic Article
GET IT
Times cited: 13 -
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Research.
2014
Academic Article
GET IT
Times cited: 25 -
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.
Breast Cancer Research.
2014
Academic Article
GET IT
Times cited: 40 -
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Journal of Clinical Oncology.
2013
Review
GET IT
Times cited: 208 -
American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.
Journal of Clinical Oncology.
2009
Review
GET IT
Times cited: 206 -
A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor.
Cancer Research.
2002
Academic Article
GET IT
Times cited: 183 -
Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.
Cancer Research.
2002
Academic Article
GET IT
Times cited: 173 -
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: Results of an international study.
American Journal of Human Genetics.
1998
Academic Article
GET IT
Times cited: 124 - Benefits and Risks of Screening Mammography in Women With BRCA1 and BRCA2 Mutations-Reply. JAMA Surgery. 1997 Information Resource GET IT
-
Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2.
JAMA - Journal of the American Medical Association.
1997
Conference Paper
GET IT
Times cited: 847